The Tax Cuts and Jobs Act of 2017 (TCJA) resulted in significant changes to the treatment of research and experimental (R&E) expenditures under Internal Revenue Code Sec. 174 that will require substantial work for many companies to implement during 2022. While it was known that a change was coming, many taxpayers continued to hope that the mandatory capitalization would be repealed or postponed.

Read More